3 Spectacular Dividend Stocks to Buy in July
A new month is here. And with it comes a new opportunity to invest in spectacular dividend stocks.
Three Motley Fool contributors think they know some great candidates to buy in July. Here's why they picked (NYSE: ABBV), Bristol Myers Squibb (NYSE: BMY), and Johnson Johnson (NYSE: JNJ).
Keith Speights (AbbVie): If you're in the market for a high dividend yield, AbbVie could be right up your alley. The big pharmaceutical company's dividend yield currently stands at nearly 4.5%.
Source Fool.com
AbbVie Inc. Aktie
Überwältigende Zustimmung für AbbVie Inc. mit ausschließlich Buy-Einschätzungen.
Ein positives, wenn auch bescheidenes, Potenzial für AbbVie Inc. mit einem Kursziel von 180 € im Vergleich zum aktuellen Kurs von 171.0 €.